Navigation Links
Seasonal Influenza Activity Increasing Across Europe - H3N2 Dominant Strain
Date:1/19/2009

inues to support the activities of the Neuraminidase Inhibitor Susceptibility Network (NISN).

Sensitivity of H5N1 (bird flu) to Tamiflu

Recently published data confirms that the H5N1 avian influenza (bird flu) strain remains sensitive to Tamiflu. Greater than ninety nine percent of H5N1 samples studied did not exhibit mutations that confer oseltamivir resistance.(3)

According to Benjamin Schwartz, MD, CDC National Vaccine Program Office, "the mutations that have made the H1N1 virus resistant are unlikely to occur in a pandemic virus, so therefore we have not changed our recommendations for planning and stockpiling".(4) Tamiflu remains the World Health Organization's "primary recommended antiviral agent of choice for the treatment of A(H5N1) virus infections".(5)

References

(1) EISS - Weekly Electronic Bulletin Week 2 :05/01/2009-11/01/2009 16 January 2009, Issue No 287

(2) The Centres for Disease Control and Prevention (CDC). Interim Antiviral Guidance for 2008-09 http://www2a.cdc.gov/HAN/ArchiveSys/ViewMsgV.asp?AlertNum=00279 Accessed 6 January 2009

(3) Hill AW et al. Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza. Infections, Genetics and Evolution. 2008

(4) 'Cost, resistance aired in HHS webcast on antivirals'. CIDRAP News. December 17 2008 http://www.cidrap.umn.edu/cidrap/content/influenza/panflu/news/dec1708webinar. html Accessed 16 January 2009

(5) Clinical management of human infection with avian influenza A(H5N1) virus. World Health Organization. 15 August 2007 http://www.who.int/csr/
'/>"/>

SOURCE Roche
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Novavax to Present Seasonal Influenza Data Results in an Investor Conference Call on December 11, 2008
2. Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial
3. Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate
4. Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season
5. Rising H9N2 Influenza Replikin Count Has Doubled That of H5N1
6. DaVita Launches Flu Fighter Program in Support of National Influenza Week
7. Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza
8. A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks
9. BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza
10. Peramivir Phase 2 Data for the Treatment of Outpatient Influenza to be Presented at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
11. MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: N...today that the company will be presenting at the 2... 2, 2009 at 12:30 pm local time at The New York Pa...of the company,s business strategy, research and d...nk to the live audio only presentation can be acce...
(Date:11/30/2009)...0 Biopharmaceutical company Kiadis...ve been enrolled in its,multinational registration...ed to show reduction in transplant related mortali...em cell transplantation with a mismatched,(haplo-i...for an allogeneic,stem cell transplantation but wi...
(Date:11/30/2009)...d LOS ANGELES, Nov. 30 /PRNewswire-Asia-FirstCall/...tin Board: CYXN; ,China Yongxin,Pharmaceuticals, o...tor and,retailer of pharmaceuticals in Northeaster...ion for distribution of medicines on the Essential...ntly formalized the nation,s Essential Drug,List w...
(Date:11/30/2009)...Newswire-FirstCall/ -- BioMarin Pharmaceutical Inc...nd Drug Administration (FDA) has granted orphan dr...amifampridine phosphate, for the rare autoimmune d...3,4-DAP has previously received orphan drug design...ittee for Medicinal Products for Human Use of the ...
Breaking Biology Technology:NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4
...sedly a banner year for venture capital investment...ers MoneyTree report, which is based on data from ... what does this mean for the life science industry... more particularly, what does it mean for the Midw...rill down to this level and find out (I can hear t...
... it again. He,s making sensational, not entirely a...business based on current conditions, which is nic...rd Business Review published an article by Carr ti...s that IT is now ubiquitous and available to all w...inable competitive advantage. , ,Even discounting ...
...ring we just escaped January a notoriously depres... the cold, dark and dank weather thats no surpris...t January 24 (just one week ago) was the most depr...reneurs already bear an extra psychological burden...sion might have escalated last month for reasons t...
Other Biology Technology:Life-science sector grabbed VC investment in 2004 2Life-science sector grabbed VC investment in 2004 3Whining should not get in the way of innovation 2Whining should not get in the way of innovation 3Post-January, tech entrepreneurs have reasons to be depressed 2Post-January, tech entrepreneurs have reasons to be depressed 3Post-January, tech entrepreneurs have reasons to be depressed 4
(Date:11/30/2009)...ity of Pittsburgh team overcame a major hurdle pla...se that could lead to more efficient catalysts use...toxic. The researchers reported Nov. 29 in Nature...ature stability in metallic nanoparticles, the vau...rability to extreme heat. , Gtz Veser, an associ...
(Date:11/30/2009)... Journal of Experimental Biology are pleased to a... de la Recherche Scientifique (CNRS) in the Univer... year,s JEB Outstanding Paper Prize. ,The prize ...ement and is intended to encourage young scientist..., and adds that ,we truly appreciate when authors ...
(Date:11/30/2009)...ower early bird registration rates and register on... 2010 at http://www.iofwco-ecceo10.org/ , WHA...rnational Osteoporosis Foundation (IOF) and the Eu...f Osteoporosis and Osteoarthritis (ESCEO). More th...pected to attend. The exciting scientific programm...
Breaking Biology News(10 mins):First metallic nanoparticles resistant to extreme heat 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4Second Generation Female Condom is Now Available in the United States 3B FC2 Female Condom Will Cost 30 Percent Less than Predecessor 5154 1Second Generation Female Condom is Now Available in the United States 3B FC2 Female Condom Will Cost 30 Percent Less than Predecessor 5154 2Second Generation Female Condom is Now Available in the United States 3B FC2 Female Condom Will Cost 30 Percent Less than Predecessor 5154 3Second Generation Female Condom is Now Available in the United States 3B FC2 Female Condom Will Cost 30 Percent Less than Predecessor 5154 4Health Strategies Group Introduces Oncology Performance Edge 5150 1Health Strategies Group Introduces Oncology Performance Edge 5150 2Health Strategies Group Introduces Oncology Performance Edge 5150 3Scientists decipher missing piece of first responder DNA repair machine 58671 1Scientists decipher missing piece of first responder DNA repair machine 58671 2Scientists decipher missing piece of first responder DNA repair machine 58671 3
...w vaccine aimed at preventing cervical cancer is n...of the human papillomavirus (HPV) responsible for ...wide study of the vaccine will be published in the...e. , Cervical cancer is the second most common cau...in nearly half a million diagnoses and 240,000 dea...
...scientific evidence is helping to build a compelli...adjunctive treatment for many cancers. , Reovir...lgary, Alberta-based Oncolytics Biotech, has shown...mor cells, in animal models, and in human clinical...ion, Reolysin®, is active against numerous cancers...
...archers at UNIVET, a spin-off of the Universitat A...al nutrition company Affinity Petcare, have develo...reproduces the characteristics of dog’s skin and w...rious lines of research related to skin biology an..., The basic structure of skin consists of an exter...
Other Biology News:Study shows continued success for new HPV vaccine against virus responsible for cervical cancer 2Dealing deadly cancers a knockout punch 2Dealing deadly cancers a knockout punch 3
Tricyclic Antidepressents ELISA Kit, Single from Bio-Quant Inc.
VZV IgM ELISA Kit, Single from Bio-Quant Inc.
Scion Image for Windows from Scion Corporation
...mbion's custom siRNA service provides the premium ...search. Custom siRNAs can be readily ordered onlin...ce, or by providing the sense and antisense siRNA ...ated and Silencer Pre-designed siRNAs, which are a...
Biology Products: